N/A
Manufactured by Boiron
31 FDA adverse event reports analyzed
Last updated: 2026-04-15
INFLUENZINUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Boiron. The most commonly reported adverse reactions for INFLUENZINUM include ANGIOEDEMA, AORTIC DILATATION, BACK PAIN, BLOOD PRESSURE INCREASED, CEREBROVASCULAR ACCIDENT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for INFLUENZINUM.
Out of 2 classified reports for INFLUENZINUM:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 31 FDA FAERS reports that mention INFLUENZINUM. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ANGIOEDEMA, AORTIC DILATATION, BACK PAIN, BLOOD PRESSURE INCREASED, CEREBROVASCULAR ACCIDENT, CONTUSION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Boiron in connection with INFLUENZINUM. Always verify the specific product and NDC with your pharmacist.